Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study

References

• Chastre, J.; Fagon, J.-Y. Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med. 2002, 165(7), 867–903. DOI: 10.1164/ajrccm.165.7.2105078.
   PubMed Web of Science ®Google Scholar
• Blot, S.; Lisboa, T.; Angles, R.; Rello, J. Prevention of VAP: Is Zero Rate Possible? Clinics Chest Med. 2011, 32(3), 591–599. DOI: 10.1016/j.ccm.2011.05.008.
   PubMed Web of Science ®Google Scholar
• Koulenti, D.; Tsigou, E.; Rello, J. Nosocomial Pneumonia in 27 ICUs in Europe: Perspectives from the EU-VAP/CAP Study. Eur. J. Clin. Microbiol. Infect Dis. 2017, 36(11), 1999–2006. DOI: 10.1007/s10096-016-2703-z.
   PubMed Web of Science ®Google Scholar
• Heyland, D. K.; Cook, D. J.; Griffith, L.; Keenan, S. P.; Brun-Buisson, C. The Attributable Morbidity and Mortality of Ventilator-associated Pneumonia in the Critically Ill Patient. Am. J. Respir. Crit. Care Med. 1999, 159(4), 1249–1256. DOI: 10.1164/ajrccm.159.4.9807050.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases. 2016;63(5):e61- e111.
   Google Scholar
• Wenzler, E.; Fraidenburg, D. R.; Scardina, T.; Danziger, L. H. Inhaled Antibiotics for Gram-negative Respiratory Infections. Clin Microbiol Rev. 2016, 29(3), 581–632. DOI: 10.1128/CMR.00101-15.
   PubMed Web of Science ®Google Scholar
• Gelfand, M. S.; Cleveland, K. O. Ceftolozane/Tazobactam Therapy of Respiratory Infections Due to Multidrug-resistant Pseudomonas aeruginosa. Clin. Infect. Dis. 2015, 61(5), 853–855. DOI: 10.1093/cid/civ411.
   PubMed Web of Science ®Google Scholar
• Rattanaumpawan, P.; Lorsutthitham, J.; Ungprasert, P.; Angkasekwinai, N.; Thamlikitkul, V. Randomized Controlled Trial of Nebulized Colistimethate Sodium as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Gram-negative Bacteria. J. Antimicrob. Chemother. 2010, 65(12), 2645–2649. DOI: 10.1093/jac/dkq360.
   PubMed Web of Science ®Google Scholar
• Liapikou, A.; Cilloniz, C.; Mensa, J.; Torres, A. New Antimicrobial Approaches to Gram Positive Respiratory Infections. Pulm. Pharmacol. Ther. 2015, 32, 137–143. DOI: 10.1016/j.pupt.2014.05.003.
   PubMed Web of Science ®Google Scholar
• Fagon J-y, Chastre J, Domart Y, Trouillet J-L, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. American Review of Respiratory Disease. 1989;139(4):877-84.
   Google Scholar
• Zilberberg, M. D.; Shorr, A. F. Ventilator-associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome. Clin. Infect. Dis. 2010, 51(Supplement_1), S131–S5. DOI: 10.1086/653062.
   PubMedGoogle Scholar
• Kollef, M. H.; Ricard, J.-D.; Roux, D.; Francois, B.; Ischaki, E.; Rozgonyi, Z.; Boulain, T.; Ivanyi, Z.; János, G.; Garot, D.; et al. A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-negative Ventilator-associated Pneumonia: IASIS Trial. Chest. 2017, 151(6), 1239–1246.
   PubMed Web of Science ®Google Scholar
• Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby J-J, et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. American journal of respiratory and critical care medicine. 2011;184(1):106-15.
   Google Scholar
• Luyt, C.-E.; Combes, A.; Nieszkowska, A.; Trouillet, J.-L.; Chastre, J. Aerosolized Antibiotics to Treat Ventilator-associated Pneumonia. Curr. Opin. Infect. Dis. 2009, 22(2), 154–158. DOI: 10.1097/QCO.0b013e328322a006.
   PubMed Web of Science ®Google Scholar
• Cole, P. The Role of Nebulized Antibiotics in Treating Serious Respiratory Infections. J. Chemother. 2001, 13(4), 354–362. DOI: 10.1179/joc.2001.13.4.354.
   PubMed Web of Science ®Google Scholar
• Gursel, G.; Demirtas, S. Value of APACHE II, SOFA and CPIS Scores in Predicting Prognosis in Patients with Ventilator-associated Pneumonia. Respiration. 2006, 73(4), 503–508. DOI: 10.1159/000088708.
   PubMed Web of Science ®Google Scholar
• Luyt C-E, Chastre J, Fagon J-Y, Group VT. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive care medicine. 2004;30(5):844-52.
   Google Scholar
• Ding, H.; Zhou, H.; Diao, M.; Xu, Y.; Pan, Q.; Shen, X. A Novel Biomarker of Serum Histidine-Rich Glycoprotein (HRG) for Diagnosing and Predicting Prognosis of Ventilator-associated Pneumonia (VAP): A Pilot Study. Eur. Rev. Med. Pharmacol. Sci. 2018, 22(22), 7920–7927. DOI: 10.26355/eurrev_201811_16419.
   PubMed Web of Science ®Google Scholar
• Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. American journal of respiratory and critical care medicine. 1995;152(6):1982-91.
   Google Scholar
• Falagas, M. E.; Kasiakou, S. K.; Saravolatz, L. D. Colistin: The Revival of Polymyxins for the Management of Multidrug-resistant Gram-negative Bacterial Infections. Clin. Infect. Dis. 2005, 40(9), 1333–1341. DOI: 10.1086/429323.
   PubMed Web of Science ®Google Scholar
• Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet infectious diseases. 2006;6(9):589-601.
   Google Scholar
• Rocco, M.; Montini, L.; Alessandri, E.; Venditti, M.; Laderchi, A.; De Gennaro, P.; Raponi, G.; Vitale, M.; Pietropaoli, P.; Antonelli, M.; et al. Risk Factors for Acute Kidney Injury in Critically Ill Patients Receiving High Intravenous Doses of Colistin Methanesulfonate and/or Other Nephrotoxic Antibiotics: A Retrospective Cohort Study. Crit. Care. 2013, 17(4), R174.
   PubMed Web of Science ®Google Scholar
• Ozkan G, Ulusoy S, Orem A, Alkanat M, Mungan S, Yulug E, et al. How does colistin-induced nephropathy develop and can it be treated? Antimicrobial agents and chemotherapy. 2013;57(8):
   Google Scholar
• Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clinical infectious diseases. 2011;53(9):879-84.
   Google Scholar